Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis

<p>Abstract</p> <p>Background</p> <p>Heat shock protein 70, a stress protein, has been implicated in tumor progression. However, its role in nasopharyngeal carcinoma (NPC) progression has not yet been clearly investigated.</p> <p>Methods</p> <p>I...

Full description

Bibliographic Details
Main Authors: Cai Man-Bo, Wang Xiao-Pai, Zhang Jia-Xing, Han Hui-Qiong, Liu Chao-Chun, Bei Jin-Xin, Peng Ruo-Jun, Liang Yi, Feng Qi-Sheng, Wang Hai-Yun, Chen Li-Zhen, Fu Sha, Kang Tiebang, Shao Jian-Yong, Zeng Yi-Xin
Format: Article
Language:English
Published: BMC 2012-05-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://www.translational-medicine.com/content/10/1/96
Description
Summary:<p>Abstract</p> <p>Background</p> <p>Heat shock protein 70, a stress protein, has been implicated in tumor progression. However, its role in nasopharyngeal carcinoma (NPC) progression has not yet been clearly investigated.</p> <p>Methods</p> <p>Immunohistochemistry (IHC) was employed to examine the expression patterns of Hsp70, human leukocyte antigen –A (HLA-A) in NPC tissue samples.</p> <p>Results</p> <p>The expression of Hsp70 exhibited different spatial patterns among nuclear, membrane and cytoplasm in 507 NPC tumor tissues. Kaplan-Meier survival analysis demonstrated that different Hsp70 expression patterns are correlated with different patient outcomes. High membranal and cytoplasmic levels of Hsp70 predicted good survival of patients. In contrast, high nuclear abundance of Hsp70 correlated with poor survival. Moreover, the membranal and cytoplasmic levels of Hsp70 were positively correlated with levels of the MHC I molecule HLA-A.</p> <p>Conclusions</p> <p>Different Hsp70 expression patterns had distinct predictive values. The different spatial abundance of Hsp70 may imply its important role in NPC development and provide insight for the development of novel therapeutic strategies involving immunotherapy for NPC.</p>
ISSN:1479-5876